G0F 2AB (500pmol/vial)1vial

(R)-1-METHYL-3-AMINOMETHYL-PIPERIDINE 2HCL, 95.0%, 5g

2-Bromo-4-fluoro-4'-methyl-1,1'-biphenyl, 98%, 1g

2-{[(4-chlorophenyl)methyl]amino}-6-methyl-3,4-dihydropyrimidin-4-one, 95.0%, 100mg

4-Methyl-3-((1-methyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-N-(3-(trifluoromethyl)phenyl)benzamide, 98%, 25mg

2-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-4-amine dihydrochloride, 95.0%, 250mg

4-(4-Bromophenyl)dibenzofuran>98.0%(GC)1g

3,5-dimethyl-4'-morpholinomethyl benzophenone, 97.0%, 1g

N-Hydroxyphthalimide>99.0%(T)500g

Ethyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-3-carboxylate, 97%, 10g

3-Bromo-2,5-dimethylpyridine, 95.0%, 1g

(S)-2-Amino-2-(3,5-dimethoxyphenyl)ethanol, 97%, 100mg

Methyl 1-oxo-1,2-dihydroisoquinoline-3-carboxylate, 95.0%, 1g